nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—Vaginal discharge—Varenicline—nicotine dependence	0.0312	0.0406	CcSEcCtD
Fluconazole—Menorrhagia—Varenicline—nicotine dependence	0.0257	0.0333	CcSEcCtD
Fluconazole—Scotoma—Varenicline—nicotine dependence	0.025	0.0325	CcSEcCtD
Fluconazole—Fungal infection—Varenicline—nicotine dependence	0.0246	0.032	CcSEcCtD
Fluconazole—Acne—Varenicline—nicotine dependence	0.0226	0.0293	CcSEcCtD
Fluconazole—Lacrimation increased—Varenicline—nicotine dependence	0.0206	0.0268	CcSEcCtD
Fluconazole—Salivary hypersecretion—Varenicline—nicotine dependence	0.0184	0.024	CcSEcCtD
Fluconazole—Urine output increased—Varenicline—nicotine dependence	0.0172	0.0223	CcSEcCtD
Fluconazole—Hypertonia—Varenicline—nicotine dependence	0.0166	0.0216	CcSEcCtD
Fluconazole—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0166	0.0721	CbGpPWpGaD
Fluconazole—Polyuria—Varenicline—nicotine dependence	0.0157	0.0204	CcSEcCtD
Fluconazole—Deafness—Varenicline—nicotine dependence	0.0154	0.02	CcSEcCtD
Fluconazole—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.015	0.065	CbGpPWpGaD
Fluconazole—Hot flush—Varenicline—nicotine dependence	0.0147	0.0191	CcSEcCtD
Fluconazole—Menopausal symptoms—Varenicline—nicotine dependence	0.0146	0.019	CcSEcCtD
Fluconazole—Thirst—Varenicline—nicotine dependence	0.0145	0.0188	CcSEcCtD
Fluconazole—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.014	0.0609	CbGpPWpGaD
Fluconazole—CYP11B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0138	0.0601	CbGpPWpGaD
Fluconazole—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0137	0.0593	CbGpPWpGaD
Fluconazole—Dry skin—Varenicline—nicotine dependence	0.0126	0.0164	CcSEcCtD
Fluconazole—Hypokalaemia—Varenicline—nicotine dependence	0.0125	0.0163	CcSEcCtD
Fluconazole—Breast disorder—Varenicline—nicotine dependence	0.0125	0.0162	CcSEcCtD
Fluconazole—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.012	0.0521	CbGpPWpGaD
Fluconazole—CYP11B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0114	0.0493	CbGpPWpGaD
Fluconazole—Infestation NOS—Varenicline—nicotine dependence	0.0106	0.0138	CcSEcCtD
Fluconazole—Infestation—Varenicline—nicotine dependence	0.0106	0.0138	CcSEcCtD
Fluconazole—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0105	0.0137	CcSEcCtD
Fluconazole—Stomatitis—Varenicline—nicotine dependence	0.0104	0.0135	CcSEcCtD
Fluconazole—Hepatobiliary disease—Varenicline—nicotine dependence	0.01	0.0131	CcSEcCtD
Fluconazole—Hallucination—Varenicline—nicotine dependence	0.00949	0.0123	CcSEcCtD
Fluconazole—Urinary tract disorder—Varenicline—nicotine dependence	0.00942	0.0122	CcSEcCtD
Fluconazole—Connective tissue disorder—Varenicline—nicotine dependence	0.00937	0.0122	CcSEcCtD
Fluconazole—Urethral disorder—Varenicline—nicotine dependence	0.00935	0.0121	CcSEcCtD
Fluconazole—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00929	0.0403	CbGpPWpGaD
Fluconazole—Visual impairment—Varenicline—nicotine dependence	0.00919	0.0119	CcSEcCtD
Fluconazole—Erythema multiforme—Varenicline—nicotine dependence	0.00902	0.0117	CcSEcCtD
Fluconazole—Eye disorder—Varenicline—nicotine dependence	0.00891	0.0116	CcSEcCtD
Fluconazole—Cardiac disorder—Varenicline—nicotine dependence	0.00885	0.0115	CcSEcCtD
Fluconazole—Angiopathy—Varenicline—nicotine dependence	0.00865	0.0112	CcSEcCtD
Fluconazole—Immune system disorder—Varenicline—nicotine dependence	0.00861	0.0112	CcSEcCtD
Fluconazole—Mediastinal disorder—Varenicline—nicotine dependence	0.0086	0.0112	CcSEcCtD
Fluconazole—Chills—Varenicline—nicotine dependence	0.00856	0.0111	CcSEcCtD
Fluconazole—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00847	0.0368	CbGpPWpGaD
Fluconazole—Mental disorder—Varenicline—nicotine dependence	0.00836	0.0109	CcSEcCtD
Fluconazole—Malnutrition—Varenicline—nicotine dependence	0.0083	0.0108	CcSEcCtD
Fluconazole—Flatulence—Varenicline—nicotine dependence	0.00818	0.0106	CcSEcCtD
Fluconazole—Dysgeusia—Varenicline—nicotine dependence	0.00813	0.0106	CcSEcCtD
Fluconazole—Back pain—Varenicline—nicotine dependence	0.00803	0.0104	CcSEcCtD
Fluconazole—Tremor—Varenicline—nicotine dependence	0.00778	0.0101	CcSEcCtD
Fluconazole—Ill-defined disorder—Varenicline—nicotine dependence	0.0077	0.01	CcSEcCtD
Fluconazole—Anaemia—Varenicline—nicotine dependence	0.00767	0.00997	CcSEcCtD
Fluconazole—Agitation—Varenicline—nicotine dependence	0.00763	0.00991	CcSEcCtD
Fluconazole—Angioedema—Varenicline—nicotine dependence	0.00759	0.00986	CcSEcCtD
Fluconazole—Malaise—Varenicline—nicotine dependence	0.00749	0.00973	CcSEcCtD
Fluconazole—Vertigo—Varenicline—nicotine dependence	0.00746	0.00969	CcSEcCtD
Fluconazole—Convulsion—Varenicline—nicotine dependence	0.00719	0.00935	CcSEcCtD
Fluconazole—Hypertension—Varenicline—nicotine dependence	0.00717	0.00931	CcSEcCtD
Fluconazole—Myalgia—Varenicline—nicotine dependence	0.00707	0.00918	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00702	0.00912	CcSEcCtD
Fluconazole—Discomfort—Varenicline—nicotine dependence	0.00698	0.00907	CcSEcCtD
Fluconazole—Dry mouth—Varenicline—nicotine dependence	0.00691	0.00898	CcSEcCtD
Fluconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0069	0.0299	CbGpPWpGaD
Fluconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00681	0.0296	CbGpPWpGaD
Fluconazole—Nervous system disorder—Varenicline—nicotine dependence	0.00665	0.00863	CcSEcCtD
Fluconazole—Thrombocytopenia—Varenicline—nicotine dependence	0.00663	0.00862	CcSEcCtD
Fluconazole—Skin disorder—Varenicline—nicotine dependence	0.00658	0.00855	CcSEcCtD
Fluconazole—Hyperhidrosis—Varenicline—nicotine dependence	0.00655	0.00851	CcSEcCtD
Fluconazole—Anorexia—Varenicline—nicotine dependence	0.00646	0.00839	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00641	0.0278	CbGpPWpGaD
Fluconazole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00617	0.00802	CcSEcCtD
Fluconazole—Insomnia—Varenicline—nicotine dependence	0.00613	0.00796	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—CYP2A7—nicotine dependence	0.00604	0.0262	CbGpPWpGaD
Fluconazole—Somnolence—Varenicline—nicotine dependence	0.00602	0.00783	CcSEcCtD
Fluconazole—Dyspepsia—Varenicline—nicotine dependence	0.00596	0.00775	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00595	0.0258	CbGpPWpGaD
Fluconazole—Decreased appetite—Varenicline—nicotine dependence	0.00589	0.00765	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00585	0.0076	CcSEcCtD
Fluconazole—Fatigue—Varenicline—nicotine dependence	0.00584	0.00759	CcSEcCtD
Fluconazole—Constipation—Varenicline—nicotine dependence	0.00579	0.00753	CcSEcCtD
Fluconazole—Pain—Varenicline—nicotine dependence	0.00579	0.00753	CcSEcCtD
Fluconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00559	0.0243	CbGpPWpGaD
Fluconazole—Feeling abnormal—Varenicline—nicotine dependence	0.00558	0.00726	CcSEcCtD
Fluconazole—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00558	0.0242	CbGpPWpGaD
Fluconazole—Gastrointestinal pain—Varenicline—nicotine dependence	0.00554	0.0072	CcSEcCtD
Fluconazole—Urticaria—Varenicline—nicotine dependence	0.00538	0.00699	CcSEcCtD
Fluconazole—Abdominal pain—Varenicline—nicotine dependence	0.00536	0.00696	CcSEcCtD
Fluconazole—Body temperature increased—Varenicline—nicotine dependence	0.00536	0.00696	CcSEcCtD
Fluconazole—Hypersensitivity—Varenicline—nicotine dependence	0.00499	0.00649	CcSEcCtD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00499	0.0216	CbGpPWpGaD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00492	0.0214	CbGpPWpGaD
Fluconazole—Asthenia—Varenicline—nicotine dependence	0.00486	0.00632	CcSEcCtD
Fluconazole—Pruritus—Varenicline—nicotine dependence	0.00479	0.00623	CcSEcCtD
Fluconazole—Diarrhoea—Varenicline—nicotine dependence	0.00464	0.00602	CcSEcCtD
Fluconazole—Dizziness—Varenicline—nicotine dependence	0.00448	0.00582	CcSEcCtD
Fluconazole—Vomiting—Varenicline—nicotine dependence	0.00431	0.0056	CcSEcCtD
Fluconazole—Rash—Varenicline—nicotine dependence	0.00427	0.00555	CcSEcCtD
Fluconazole—Dermatitis—Varenicline—nicotine dependence	0.00427	0.00555	CcSEcCtD
Fluconazole—Headache—Varenicline—nicotine dependence	0.00424	0.00552	CcSEcCtD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00404	0.0176	CbGpPWpGaD
Fluconazole—Nausea—Varenicline—nicotine dependence	0.00402	0.00523	CcSEcCtD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00386	0.0167	CbGpPWpGaD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00381	0.0165	CbGpPWpGaD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00352	0.0153	CbGpPWpGaD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00347	0.0151	CbGpPWpGaD
Fluconazole—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00315	0.0137	CbGpPWpGaD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00313	0.0136	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00297	0.0129	CbGpPWpGaD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00293	0.0127	CbGpPWpGaD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00285	0.0124	CbGpPWpGaD
Fluconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00232	0.0101	CbGpPWpGaD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00229	0.00993	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00228	0.00989	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00215	0.00932	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00212	0.00919	CbGpPWpGaD
Fluconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00188	0.00816	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00176	0.00765	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00166	0.00721	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00164	0.00711	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00161	0.00697	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00151	0.00657	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00149	0.00648	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00106	0.0046	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP2A7—nicotine dependence	0.00103	0.00448	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000998	0.00433	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000985	0.00427	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000592	0.00257	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000508	0.00221	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000367	0.00159	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000284	0.00123	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000277	0.0012	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000259	0.00112	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000171	0.000741	CbGpPWpGaD
